Esperion Therapeutics
ESPR
$1.90
Share price
-4.52%
Change (1 day)
43.94%
Change (1 year)
Categories
Esperion Therapeutics (ESPR) - Net assets
Net assets on the balance sheet as of December 2023 : -$0.46 B
According to Esperion Therapeutics's latest financial reports the company has -$0.46 B in net assets.
A company’s net assets is the sum of its assets minus the sum of its liabilities.
Esperion Therapeutics - Net assets on balance sheet (from 2001 to 2023)
Net assets by year
| Year | Net assets | Change |
|---|---|---|
| 2023-12-31 | $-0.46 B | 40.53% |
| 2022-12-31 | $-0.33 B | 64.4% |
| 2021-12-31 | $-0.2 B | 104.86% |
| 2020-12-31 | $-96.14 M | -581.87% |
| 2019-12-31 | $19.95 M | -74.78% |
| 2018-12-31 | $79.11 M | -67.67% |
| 2017-12-31 | $0.24 B | 7.04% |
| 2016-12-31 | $0.22 B | -20.42% |
| 2015-12-31 | $0.28 B | 115.09% |
| 2014-12-31 | $0.13 B | 80.26% |
| 2013-12-31 | $74.09 M | -526.06% |
| 2012-12-31 | $-17.39 M | 187.11% |
| 2011-12-31 | $-6.06 M | |
| 2002-12-31 | $38.74 M | -41.74% |
| 2001-12-31 | $66.49 M |
Net assets for similar companies or competitors
| Company | Net assets | differencediff. | Country |
|---|---|---|---|
 Pfizer PFE | $89.28 B | -19,724.00% | 🇺🇸 USA |
 Regeneron Pharmaceuticals REGN | $25.97 B | -5,808.45% | 🇺🇸 USA |
 Ultragenyx RARE | $0.27 B | -160.53% | 🇺🇸 USA |
 Lexicon Pharmaceuticals
LXRX | $93.11 M | -120.46% | 🇺🇸 USA |
 Amicus Therapeutics
FOLD | $0.16 B | -135.20% | 🇺🇸 USA |
 BioMarin Pharmaceutical BMRN | $4.95 B | -1,188.27% | 🇺🇸 USA |